Fortive CorpFTV
▲ PositiveCapitalrelevance
Beats Q2 estimates and raises full-year EPS guidance
Impact on stocks 1
Biotech & Genomic Medicine
Fortive CorpFortive reported second-quarter revenue of $1.10 billion, beating analyst estimates of $1.07 billion and growing 7.9% year on year. Adjusted earnings per share came in at $0.74, surpassing the consensus of $0.71 by 4.9%. Management raised its full-year adjusted EPS guidance to $3 at the midpoint, a 1.7% increase, while adjusted EBITDA reached $322.7 million with a 29.4% margin. The company highlighted strong organic growth driven by new product introductions at Fluke and expanded AI-enabled software offerings, though shares declined following the results amid product mix and regional headwinds in EMEA.
Fortive CorpBeats Q2 estimates and raises full-year EPS guidance